TruthArchive.ai - Tweets Saved By @CDCDirector

Posted - November 8, 2023 at 6:27 PM

Saved - November 9, 2023 at 6:07 PM

@CDCDirector - Mandy K. Cohen, MD, MPH

In the studio today talking about flu, Covid, and RSV vaccines! Thanksgiving is in 2 weeks — make a plan today to get vaccinated against the major respiratory viruses to protect yourself and your loved ones 💪 https://t.co/XjCBFSw8Kb

@CDCDirector — Mandy K. Cohen, MD, MPH

Posted - September 28, 2023 at 6:35 PM

Saved - September 29, 2023 at 3:31 PM

@CDCDirector - Mandy K. Cohen, MD, MPH

For the first time, we have vaccines to protect against the 3 major winter respiratory viruses — Covid, Flu, and RSV Learn more

@NFIDVaccines - NFID

At 2023 #NFID News Conference, @CDCDirector shares thoughts on what to expect for the upcoming 2023-2024 respiratory season nfid.org/2023flunews #GetVaccinated #FightFlu #StopTheSpread

@CDCDirector — Mandy K. Cohen, MD, MPH

Posted - September 6, 2023 at 9:01 PM

Saved - September 17, 2023 at 1:10 PM

@CDCDirector - Mandy K. Cohen, MD, MPH

It’s that time of year — I got my flu shot! Get yours to #FightFlu 💉🦠 https://t.co/ooZRB0DgUW

@whitematador - ®️©️

@CDCDirector What’s in that shot? Why are the side effects from MRNA ‘vaccines’ more common?

@CDCDirector — Rochelle Walensky, MD, MPH

Posted - May 13, 2021 at 9:31 PM

Saved - November 11, 2022 at 5:19 AM

@CDCDirector - Rochelle Walensky, MD, MPH

We have all longed for this moment - when we can get back to some sense of normalcy – and that moment has come for those who are fully vaccinated! CDC's update for those fully vaccinated against #COVID19 is based on science about vaccine effectiveness, variants, and transmission.

Video Transcript AI Summary

Multiple studies have shown the safety and effectiveness of COVID-19 vaccines. In Israel, a study found that the vaccines were 97% effective against symptomatic infection and 86% effective against asymptomatic infection in healthcare workers. In the United States, vaccines were 90% effective against any infection and 94% effective against hospitalizations from COVID-19 in healthcare workers across multiple states. The Pfizer vaccine has also been found to be effective against common variants in the US, such as B117 and B1351. Similar effectiveness has been observed with the Moderna and Johnson & Johnson vaccines. Even if someone does get infected after vaccination, the infection is likely to have a lower viral load, be shorter in duration, and have a lower risk of transmission to others.

AI Similar Videos

Full Transcript

Speaker 0: Over the course of the pandemic, we are continuously gathering data and evidence to inform our guidance and decision making. We now have numerous reports in the literature that demonstrate the safety and real world effectiveness of the authorized vaccines. On this slide, there are 3 recently published studies, 1 from Israel published in the Journal of the American Medical Association or JAMA On the top, and 2 from the United States, both published in CDC's morbidity and mortality weekly report, which all show that COVID nineteen vaccines work. In Israel, there was a demonstrated 97% vaccine effectiveness against symptomatic, And 86% effectiveness against asymptomatic infection in over 5,000 healthcare workers. In the United States, vaccines were 90% effective against any infection in nearly 4,000 healthcare workers, and 94% effective against hospitalizations from COVID nineteen in an evaluation across 24 hospitals in 14 states. Additionally, we are accumulating data that our authorized vaccines are effective against the variants that are circulating in this country. On this slide, you can see a study published just last week that demonstrates how effective the Pfizer vaccine is against the Common circulating variants in the United States, B117, as well as other variants like B1351. Additional studies confirm that the Moderna and Johnson and Johnson vaccines are also effective against circulating variants. Finally, we know that in the rare event that people get infected after a vaccine, the resulting infection is more likely to have a lower viral load, be shorter in duration, and likely less risky of transmission to others.